IFP Advisors Inc increased its stake in shares of Humana Inc. (NYSE:HUM) by 48.8% during the second quarter, Holdings Channel reports. The firm owned 3,634 shares of the insurance provider’s stock after buying an additional 1,191 shares during the period. IFP Advisors Inc’s holdings in Humana were worth $874,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in HUM. Guardian Life Insurance Co. of America boosted its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Reliance Trust Co. of Delaware boosted its stake in shares of Humana by 0.7% in the second quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock valued at $270,000 after buying an additional 8 shares during the period. Creative Planning boosted its stake in shares of Humana by 0.3% in the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after buying an additional 15 shares during the period. Sit Investment Associates Inc. boosted its stake in shares of Humana by 0.3% in the second quarter. Sit Investment Associates Inc. now owns 12,020 shares of the insurance provider’s stock valued at $2,892,000 after buying an additional 40 shares during the period. Finally, AE Wealth Management LLC boosted its stake in shares of Humana by 3.8% in the first quarter. AE Wealth Management LLC now owns 1,305 shares of the insurance provider’s stock valued at $269,000 after buying an additional 48 shares during the period. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Shares of Humana Inc. (HUM) opened at 254.96 on Thursday. The stock has a market capitalization of $36.85 billion, a P/E ratio of 20.97 and a beta of 0.91. Humana Inc. has a one year low of $163.50 and a one year high of $255.10. The stock’s 50 day moving average is $238.81 and its 200-day moving average is $222.35.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same period in the prior year, the firm earned $2.30 earnings per share. On average, equities research analysts expect that Humana Inc. will post $11.45 EPS for the current year.

TRADEMARK VIOLATION WARNING: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.watchlistnews.com/humana-inc-nysehum-position-raised-by-ifp-advisors-inc/1466931.html.

Several brokerages recently commented on HUM. Cowen and Company reiterated an “outperform” rating and issued a $230.00 price objective on shares of Humana in a research note on Tuesday, April 25th. Leerink Swann raised their price objective on shares of Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a research note on Tuesday, May 30th. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $257.00 price objective for the company in a research note on Thursday, May 25th. BidaskClub cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Finally, UBS AG reiterated a “neutral” rating and issued a $237.00 price objective (up previously from $205.00) on shares of Humana in a research note on Wednesday, June 28th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $243.65.

In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the company’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the sale, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Heidi S. Margulis sold 1,500 shares of the company’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the sale, the vice president now directly owns 8,150 shares of the company’s stock, valued at $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by corporate insiders.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.